The extent of this contribution, however, might not be significant because it has been shown that SARS-CoV-2-S-specific memory B cells remain stable at least for the 6 months post-recovery ( Vaisman-Mentesh et al., 2020 ).
← all excerpts
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4<sup>+</sup> T cell help.
1
—
—